HomeAgenda

ExpertiseUpdated on 15 August 2025

AI in-silico (Q)SAR Computational Modeling & Simulation expertise

About

Tox by Design has been using Quantitative Structure-Activity Relationships (Q)SAR protocols as early as 2016. To leverage all its potential in the toxicological domain, Tox By Design has assembled an expertise of ERT board-certified toxicologists and PharmDs alongside a top PhD Organic chemist to interpret (Q)SAR data.

We recognize the brilliant future of in-silico predictive software for toxicological modeling. Computational modeling and simulation is already delivering within the drug development ecosystem, and nowhere is it exemplified more than by pharmaceutical toxicology.

In Japan, Hazard Evaluation Support System Integrated Platform (HESS), which is based on OECD QSAR Toolbox, is more and more becoming the tool of choice to discuss with Japanese Regulatory autorities, and we foresee a brillant evolution of pharma drug development using those key models.

Do not hesitate to consult our website for more information, https://www.toxby.design/ja/expertise/avicenna-alliance-computational-simulation-and-modeling-388

Field

  • Biotech, Pharma and Cosmetics

Organisation

Tox by Design | デザイン毒性学

Company (SME/startup) / 中小企業・スタートアップ

PARIS, France